BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 17055865)

  • 1. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
    Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
    Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facts and fiction in the pharmacologic prevention of post-ERCP pancreatitis: a never-ending story.
    Testoni PA
    Gastrointest Endosc; 2006 Nov; 64(5):732-4. PubMed ID: 17055866
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.
    Sherman S; Alazmi WM; Lehman GA; Geenen JE; Chuttani R; Kozarek RA; Welch WD; Souza S; Pribble J;
    Gastrointest Endosc; 2009 Mar; 69(3 Pt 1):462-72. PubMed ID: 19231487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
    Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
    Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
    Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
    Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
    Manes G; Ardizzone S; Lombardi G; Uomo G; Pieramico O; Porro GB
    Gastrointest Endosc; 2007 Jun; 65(7):982-7. PubMed ID: 17531632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
    Sternlieb JM; Aronchick CA; Retig JN; Dabezies M; Saunders F; Goosenberg E; Infantolino A; Ionna S; Maislin G; Wright SH
    Am J Gastroenterol; 1992 Nov; 87(11):1561-6. PubMed ID: 1279967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis.
    Kapetanos D; Kokozidis G; Kinigopoulou P; Xiarchos P; Antonopoulos Z; Progia E; Kitis G
    Hepatogastroenterology; 2007 Mar; 54(74):556-60. PubMed ID: 17523321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter study.
    Deenadayalu VP; Blaut U; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Temkit M; Lehman GA; Sherman S
    J Clin Gastroenterol; 2008; 42(10):1103-9. PubMed ID: 18936645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP.
    Sotoudehmanesh R; Khatibian M; Kolahdoozan S; Ainechi S; Malboosbaf R; Nouraie M
    Am J Gastroenterol; 2007 May; 102(5):978-83. PubMed ID: 17355281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP.
    Arvanitidis D; Hatzipanayiotis J; Koutsounopoulos G; Frangou E
    Hepatogastroenterology; 1998; 45(19):248-52. PubMed ID: 9496522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy.
    Arcidiacono R; Gambitta P; Rossi A; Grosso C; Bini M; Zanasi G
    Endoscopy; 1994 Nov; 26(9):715-8. PubMed ID: 7536155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does glyceryl nitrate prevent post-ERCP pancreatitis? A prospective, randomized, double-blind, placebo-controlled multicenter trial.
    Nøjgaard C; Hornum M; Elkjaer M; Hjalmarsson C; Heyries L; Hauge T; Bakkevold K; Andersen PK; Matzen P;
    Gastrointest Endosc; 2009 May; 69(6):e31-7. PubMed ID: 19410035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of octreotide versus placebo in the prevention of post-ERCP pancreatitis.
    Kisli E; Baser M; Aydin M; Guler O
    Hepatogastroenterology; 2007; 54(73):250-3. PubMed ID: 17419271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
    Lee KT; Lee DH; Yoo BM
    Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
    Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
    Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk.
    Sherman S; Cheng CL; Costamagna G; Binmoeller KF; Puespoek A; Aithal GP; Kozarek RA; Chen YK; Van Steenbergen W; Tenner S; Freeman M; Monroe P; Geffner M; Deviere J;
    Pancreas; 2009 Apr; 38(3):267-74. PubMed ID: 19214137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
    Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
    Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis.
    Masci E; Cavallini G; Mariani A; Frulloni L; Testoni PA; Curioni S; Tittobello A; Uomo G; Costamagna G; Zambelli S; Macarri G; Innocenti P; Dragonetti C;
    Am J Gastroenterol; 2003 Oct; 98(10):2182-6. PubMed ID: 14572565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial.
    Beauchant M; Ingrand P; Favriel JM; Dupuychaffray JP; Capony P; Moindrot H; Barthet M; Escourrou J; Plane C; Barrioz T; Lacoste L; Ingrand I
    Endoscopy; 2008 Aug; 40(8):631-6. PubMed ID: 18680075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.